Mobile prescription management platform raises $1m seeding funding led by Atlas Venture and including SROne.
ZappRx, a US-based mobile platform that automates the prescription management process, has closed an additional $1m in seed funding led by current investor Atlas Venture and including a new investment from SR One, the venture arm of pharmaceutical company GlaxoSmithKline.
To date, ZappRx has raised a total of $2.2M.
ZappRx will use the additional funding to further build out its prescription processing platform to meet the unique needs of the specialty pharmacy space.
Jens Eckstein, managing partner at SR One,…
